Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/34902 |
Resumo: | This prospective cohort study aimed to evaluate by echocardiogram the cardiovascular effects of α2 agents associated with butorphanol in cats. A group of 18 mixed-breed cats with a mean weight of 3.65 + 0.7 kg, with an approximate age of 6 months. The cats were assigned in three groups, XB (Xylazine/butorphanol group) sedation with 0.5 mg/kg of xylazine and 0.5 mg/kg of butorphanol IM; DB (Dexmedetomidine/butorphanol group): sedation with 20 µg/kg of dexmedetomidine and 0.5 mg/kg of butorphanol IM; C: control group which received saline solution in volume approximated to those used in the other groups, IM. Echocardiographic variables as ejection fraction (Simpson's method and M-mode) and left ventricular shortening fraction (M-mode), ejection volume, end-systolic volume and cardiac output (Teichholz), tissue Doppler E' and A' wave velocities and cardiac index were evaluated. There was a reduction in echocardiographic variables compared with the control group, being statistically significant for heart rate, ejection fraction (% by Simpson), shortening fraction (% in M-mode) and end-systolic volume in XB and DB groups, and tissue Doppler E' and A' wave velocity (m/s), E'/A' ratio, cardiac output and cardiac index only in XB group. When compared to each other, XB and DB differed significantly in the tissue Doppler E' and A' wave velocity (m/s), and E'/A' ratio. Xylazine was more deleterious than dexmedetomidine in most of the variables evaluated, leading to a significant reduction in cardiac output and cardiac index at the doses used in this study. |
id |
UNIFEI_f0b0d6c280a540258fe750af456c08d9 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/34902 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanolEvaluación ecocardiográfica de felinos sedados con dexmedetomidina o xilacina asociada a butorfanolAvaliação ecocardiográfica de felinos sedados com dexmedetomidina ou xilazina associada com butorfanolAdrenergic alpha-2 receptor agonistsCardiac OutputCatsEchocardiography.Agonistas de receptores adrenérgicos alfa 2Gasto cardíacoGatosEcocardiografía.Agonistas de receptores adrenérgicos alfa 2Débito cardíacoGatosEcocardiografia.This prospective cohort study aimed to evaluate by echocardiogram the cardiovascular effects of α2 agents associated with butorphanol in cats. A group of 18 mixed-breed cats with a mean weight of 3.65 + 0.7 kg, with an approximate age of 6 months. The cats were assigned in three groups, XB (Xylazine/butorphanol group) sedation with 0.5 mg/kg of xylazine and 0.5 mg/kg of butorphanol IM; DB (Dexmedetomidine/butorphanol group): sedation with 20 µg/kg of dexmedetomidine and 0.5 mg/kg of butorphanol IM; C: control group which received saline solution in volume approximated to those used in the other groups, IM. Echocardiographic variables as ejection fraction (Simpson's method and M-mode) and left ventricular shortening fraction (M-mode), ejection volume, end-systolic volume and cardiac output (Teichholz), tissue Doppler E' and A' wave velocities and cardiac index were evaluated. There was a reduction in echocardiographic variables compared with the control group, being statistically significant for heart rate, ejection fraction (% by Simpson), shortening fraction (% in M-mode) and end-systolic volume in XB and DB groups, and tissue Doppler E' and A' wave velocity (m/s), E'/A' ratio, cardiac output and cardiac index only in XB group. When compared to each other, XB and DB differed significantly in the tissue Doppler E' and A' wave velocity (m/s), and E'/A' ratio. Xylazine was more deleterious than dexmedetomidine in most of the variables evaluated, leading to a significant reduction in cardiac output and cardiac index at the doses used in this study.Este estudio de cohorte prospectivo tuvo como objetivo evaluar mediante ecocardiograma los efectos cardiovasculares de los agentes α2 asociados con butorfanol en gatos. Un grupo de 18 gatos mestizos con un peso medio de 3,65 + 0,7 kg, con una edad aproximada de 6 meses. Los gatos fueron asignados en tres grupos, XB (grupo xilacina/butorfanol): sedación con 0,5 mg/kg de xilacina y 0,5 mg/kg de butorfanol IM; DB (grupo Dexmedetomidina/butorfanol): sedación con 20 µg/kg de dexmedetomidina y 0,5 mg/kg de butorfanol IM; C: grupo control que recibió solución salina en volumen aproximado a los utilizados en los otros grupos, IM. Variables ecocardiográficas como fracción de eyección (método de Simpson y modo M) y fracción de acortamiento del ventrículo izquierdo (modo M), volumen de eyección, volumen telesistólico y gasto cardíaco (Teichholz), velocidades de onda Doppler tisular E' y A' e índice cardíaco fueron evaluados. Hubo una reducción en las variables ecocardiográficas en comparación con el grupo control, siendo estadísticamente significativas para frecuencia cardíaca, fracción de eyección (% por Simpson), fracción de acortamiento (% en modo M) y volumen telesistólico en los grupos XB y DB, y velocidad de onda Doppler tisular E' y A' (m/s), cociente E'/A', gasto cardíaco e índice cardíaco solo en el grupo XB. Cuando se compararon entre sí, XB y DB diferían significativamente en la velocidad de onda Doppler tisular E' y A' (m/s) y en la relación E'/A'. La xilacina fue más deletérea que la dexmedetomidina en la mayoría de las variables evaluadas, lo que provocó una reducción significativa del gasto cardíaco y del índice cardíaco a las dosis utilizadas en este estudio.Este estudo de coorte prospectivo teve como objetivo avaliar por ecocardiograma os efeitos cardiovasculares de agentes α2 associados ao butorfanol em gatos. Um grupo de 18 gatos sem raça definida com peso médio de 3,65 + 0,7 kg, com idade aproximada de 6 meses. Os gatos foram divididos em três grupos, sedação XB (grupo xilazina/butorfanol) com 0,5 mg/kg de xilazina e 0,5 mg/kg de butorfanol IM; DB (grupo Dexmedetomidina/butorfanol): sedação com 20 µg/kg de dexmedetomidina e 0,5 mg/kg de butorfanol IM; C: grupo controle que recebeu solução salina em volume próximo aos utilizados nos demais grupos, IM. Variáveis ecocardiográficas como fração de ejeção (método de Simpson e modo M) e fração de encurtamento do ventrículo esquerdo (modo M), volume de ejeção, volume sistólico e débito cardíaco (Teichholz), velocidades das ondas E' e A' do Doppler tecidual e índice cardíaco foram avaliados. Houve redução das variáveis ecocardiográficas em relação ao grupo controle, sendo estatisticamente significante para frequência cardíaca, fração de ejeção (% por Simpson), fração de encurtamento (% em modo M) e volume sistólico final nos grupos XB e DB e tecido Velocidade das ondas E' e A' Doppler (m/s), relação E'/A', débito cardíaco e índice cardíaco apenas no grupo XB. Quando comparados entre si, XB e DB diferiram significativamente na velocidade de onda E' e A' do Doppler tecidual (m/s) e na relação E'/A'. A xilazina foi mais deletéria que a dexmedetomidina na maioria das variáveis avaliadas, levando a uma redução significativa do débito cardíaco e do índice cardíaco nas doses utilizadas neste estudo.Research, Society and Development2022-09-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3490210.33448/rsd-v11i12.34902Research, Society and Development; Vol. 11 No. 12; e559111234902Research, Society and Development; Vol. 11 Núm. 12; e559111234902Research, Society and Development; v. 11 n. 12; e5591112349022525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/34902/29380Copyright (c) 2022 Tábata Torres Megda; Felipe Gaia de Sousa; Fernanda Guimarães Miranda; Maira Souza Oliveira Barreto; Cláudio Roberto Scabelo Mattoso; Suzane Lilian Beierhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMegda, Tábata Torres Sousa, Felipe Gaia de Miranda, Fernanda Guimarães Barreto, Maira Souza Oliveira Mattoso, Cláudio Roberto Scabelo Beier, Suzane Lilian 2022-09-26T11:56:08Zoai:ojs.pkp.sfu.ca:article/34902Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:50:01.082619Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol Evaluación ecocardiográfica de felinos sedados con dexmedetomidina o xilacina asociada a butorfanol Avaliação ecocardiográfica de felinos sedados com dexmedetomidina ou xilazina associada com butorfanol |
title |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol |
spellingShingle |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol Megda, Tábata Torres Adrenergic alpha-2 receptor agonists Cardiac Output Cats Echocardiography. Agonistas de receptores adrenérgicos alfa 2 Gasto cardíaco Gatos Ecocardiografía. Agonistas de receptores adrenérgicos alfa 2 Débito cardíaco Gatos Ecocardiografia. |
title_short |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol |
title_full |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol |
title_fullStr |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol |
title_full_unstemmed |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol |
title_sort |
Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol |
author |
Megda, Tábata Torres |
author_facet |
Megda, Tábata Torres Sousa, Felipe Gaia de Miranda, Fernanda Guimarães Barreto, Maira Souza Oliveira Mattoso, Cláudio Roberto Scabelo Beier, Suzane Lilian |
author_role |
author |
author2 |
Sousa, Felipe Gaia de Miranda, Fernanda Guimarães Barreto, Maira Souza Oliveira Mattoso, Cláudio Roberto Scabelo Beier, Suzane Lilian |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Megda, Tábata Torres Sousa, Felipe Gaia de Miranda, Fernanda Guimarães Barreto, Maira Souza Oliveira Mattoso, Cláudio Roberto Scabelo Beier, Suzane Lilian |
dc.subject.por.fl_str_mv |
Adrenergic alpha-2 receptor agonists Cardiac Output Cats Echocardiography. Agonistas de receptores adrenérgicos alfa 2 Gasto cardíaco Gatos Ecocardiografía. Agonistas de receptores adrenérgicos alfa 2 Débito cardíaco Gatos Ecocardiografia. |
topic |
Adrenergic alpha-2 receptor agonists Cardiac Output Cats Echocardiography. Agonistas de receptores adrenérgicos alfa 2 Gasto cardíaco Gatos Ecocardiografía. Agonistas de receptores adrenérgicos alfa 2 Débito cardíaco Gatos Ecocardiografia. |
description |
This prospective cohort study aimed to evaluate by echocardiogram the cardiovascular effects of α2 agents associated with butorphanol in cats. A group of 18 mixed-breed cats with a mean weight of 3.65 + 0.7 kg, with an approximate age of 6 months. The cats were assigned in three groups, XB (Xylazine/butorphanol group) sedation with 0.5 mg/kg of xylazine and 0.5 mg/kg of butorphanol IM; DB (Dexmedetomidine/butorphanol group): sedation with 20 µg/kg of dexmedetomidine and 0.5 mg/kg of butorphanol IM; C: control group which received saline solution in volume approximated to those used in the other groups, IM. Echocardiographic variables as ejection fraction (Simpson's method and M-mode) and left ventricular shortening fraction (M-mode), ejection volume, end-systolic volume and cardiac output (Teichholz), tissue Doppler E' and A' wave velocities and cardiac index were evaluated. There was a reduction in echocardiographic variables compared with the control group, being statistically significant for heart rate, ejection fraction (% by Simpson), shortening fraction (% in M-mode) and end-systolic volume in XB and DB groups, and tissue Doppler E' and A' wave velocity (m/s), E'/A' ratio, cardiac output and cardiac index only in XB group. When compared to each other, XB and DB differed significantly in the tissue Doppler E' and A' wave velocity (m/s), and E'/A' ratio. Xylazine was more deleterious than dexmedetomidine in most of the variables evaluated, leading to a significant reduction in cardiac output and cardiac index at the doses used in this study. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-24 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34902 10.33448/rsd-v11i12.34902 |
url |
https://rsdjournal.org/index.php/rsd/article/view/34902 |
identifier_str_mv |
10.33448/rsd-v11i12.34902 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34902/29380 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 12; e559111234902 Research, Society and Development; Vol. 11 Núm. 12; e559111234902 Research, Society and Development; v. 11 n. 12; e559111234902 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052723788513280 |